Senior Health Services Research Advisor

New Prostate Cancer Screening Guideline Recommends ‘Individualized Decisionmaking’ by Patients

The U.S. Preventive Services Task Force (USPSTF), an independent national panel of medical experts, this week released a draft revised guideline on screening for prostate cancer with the prostate-specific antigen (PSA) test. The revised guideline reverses its 2012 recommendation discouraging PSA screening among men of all races and ages. Instead, USPSTF now encourages men ages 55 to 69 to discuss the test with their physicians and decide for themselves if they want to undergo PSA screening. The draft guideline also …

Examining the Evidence on Treating Prostate Cancer: What’s a Man to Do?

Prostate cancer is the second most common cancer (next to skin cancer) and the second leading cause of death from cancer among men in the U.S. Due to the high risk of side effects associated with prostate cancer treatments, such as erectile dysfunction, urinary incontinence and fecal incontinence, physicians and consumers want to know they are choosing the best evidence-based treatment. Unfortunately, there is currently no scientific consensus to guide them. A recent study compared three treatment options for prostate …

Examining the Evidence: Do Drugs Like Nexium Increase Your Risk of Dementia?

A recent study linked some popular drugs used to treat heartburn and peptic ulcers to an increased risk of dementia.  While the study findings are concerning, consumers should be mindful that media reports do not necessarily present the full picture. Here is a breakdown of what the study actually shows: The Study Researchers wanted to know if proton pump inhibitors (PPIs), drugs commonly used to treat heartburn and peptic ulcers, were associated with dementia among older adults. Better known by …